Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution

International Journal of Obesity

Volumn 20, Issue 1, 1996, Pages 28-36

  Bonora, E ^a,b   Targher, G ^a   Branzi, P ^a   Zenere, M ^a   Saggiani, F ^a   Zenti, M G ^a   Travia, D ^a   Tonoli, M ^a   Muggeo, M ^a   Cigolini, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Age; Behavioural variables; Cardiovascular risk factors; Regional fat distribution; Total body fat content

Indexed keywords

ALCOHOL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR; BODY FAT; BODY MASS; BODY SIZE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; HUMAN; IMPEDANCE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ALCOHOL DRINKING; BLOOD PRESSURE; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EXERCISE; HUMANS; INSULIN; MALE; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 9044234013     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kannel WB et al. Serum cholesterol, lipoproteins and risk of coronary heart disease: the Framingham study. Ann Intern Med 1971; 74: 1-12.
2. Heyden S et al. Decrease of serum cholesterol level and blood pressure in the community. Arch Intern Med 1971; 128: 982-986.
3. Tyroler HA. Cholesterol and cardiovascular disease. An overwiev of Lipid Research Clinics (LRC) epidemiologic studies as background for the LRC Coronary Primary Prevention Trial. Am J Cardiol 1984; 54: 14-19.
4. Després JP et al. Effect of the amount of body fat on the age-associated increase in serum cholesterol. Prev Med 1988; 17: 423-431.
5. Burke GL et al. Population trends in serum cholesterol, treatment and control status from 1980 to 1987: The Minnesota Heart Survey. N Engl J Med 1991; 324: 941-946.
6. Ericsson S et al. Influence of age on the metabolism of plasma low density lipoprotein in healthy males. J Clin Invest 1991; 87: 591-596.
7. Neaton JD, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking and death for coronary heart disease. Overall findings and differences by age for 316099 white men. Arch Intern Med 1992; 152: 56-64.
8. Assman G. Lipid metabolism disorders and coronary heart disease. Munich: MMV Medizin Verlag, 1993.
9. Wattigney WA et al. Increasing impact of obesity on serum lipids and lipoproteins in young adults: The Bogalusa Heart Study. Arch Intern Med 1991; 151: 2017-2022.
10. Donahue RP et al. Distribution of lipoproteins and apolipoproteins in young adults: the CARDIA study. Arteriosclerosis 1989; 9: 656-664.
11. Webber LS et al. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol 1991; 133: 884-899.
12. Berenson GS, McMahan CA, Voors AW. Cardiovascular risk factors in children: the early natural history of atherosclerosis and essential hypertension. New York, NY: Oxford University Press Inc, 1980.
13. Greenland P et al. Divergent age-associated patterns of high density lipoprotein cholesterol and its percentage in Jewish and Moslem Arab Israeli children and adolescents: the Petach Tikva Project. Am J Epidemiol 1993; 137: 549-558.
14. Folsom AR et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites: the role of insulin. Am J Epidemiol 1989; 130: 911-924.
15. Shimokata H et al. Studies in the distribution of body fat: effects of age, sex and obesity J Gerontol 1989; 44: 66-73.
16. Kissebah AH, Freedman DS, Peiris AN: Health risks of obesity. Med Clin N Am 1989; 73: 111-136.
17. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143.
18. Berchtold P et al. Cardiovascular risk factors and HDL cholesterol levels in obesity. Int J Obesity 1981; 5: 1-10.
19. French SA et al. Predictors of weight change over two years among a population of working adults: the Healthy Worker Project. Int J Obes 1994; 18: 145-154.
20. Helmrick SP et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes. N Engl J Med 1991; 325: 147-152.
21. Andersen LB, Haraldsdòttir J. Tracking of cardiovascular disease risk factors including maximal oxygen uptake and physical activity from late teenage to adulthood: an 8-year follow-up study. J Int Med 1993; 234: 309-315.
22. Seidell JC. Environmental influences on regional fat distribution. Int J Obes 1991; 15(Suppl 2): 31-35.
23. Seidell JC et al. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men. The European Fat Distribution Study. Atherosclerosis 1991; 86: 251-260.
24. Bonora E et al. Influence of body fat and its regional localization on risk factors for atherosclerosis in young men. Am J Epidemiol 1992; 135: 1271-1278.
25. Segal KR et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. J Appl Physiol 1988; 47: 7-14.
26. Baecke JAH, Burema J, Frijters JIR: A short questionnaire for the measurement of physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
27. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee. Summary of 1993 World Health Organisation-International Society Hypertension guidelines for the management of mild hypertension. BMJ 1993; 307: 1541-1546.
28. Roschläu P, Bernt E. Gruber W. Enzimatische Bestimmung des Gesamt-cholesterins in serum (in German). Z Klin Chem Klin Biochem 1974; 12: 403-407.
29. 2+ precipitation procedure for quantification of high density lipoprotein cholesterol. Clin Chem 1982; 28: 1379-1388.
30. Bucolo G, David H. Quantitative determination of serum trigycerictes by use of enzyme. Clin Chem 1973; 19: 475-483.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 449-452.
32. Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J 1963; 88: 173-144.
33. Consensus Conference. Treatment of hypertriglyceridemia. JAMA 1984; 251: 1196-1201.
34. Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP). JAMA 1993; 269: 3015-3023.
35. Snedecor GW, Cochran WG. Statistical methods. Ames Iowa, Iowa State University Press, 1967.
36. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
37. Ferrannini E et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
38. Bonora E et al. Relationship between blood pressure and plasma insulin in non-obese and non-diabetic subjects. Diabetologia 1987; 30: 719-723.
39. Zavaroni I. et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
40. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
41. De Fronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095-1101.
42. Zavaroni I et al. Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population. J Am Geriatr Soc 1986; 34: 271-275.
43. Shimokata H et al. Age as independent determinant of glucose tolerance. Diabetes 1991; 40: 44-51.
44. Boden G et al. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 1993; 16: 728-733.
45. Landin K, Krotkiewski M, Smith U: Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution. Metabolism 1989; 38: 572-576.
46. Bonora E et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992; 41; 1151-1159.
47. Cigolini M et al. Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: The European Fat Distribution Study. Metabolism 1991; 40: 781-787.
48. Haffner SM et al. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
49. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811.
50. Reichley KB et al. Centralized obesity and cardiovascular disease risk in Mexican Americans. Am J Epidemiol 1987; 125: 373-386.
51. Haines AP, Imeson JD, Meade TW. Skinfold thickness and cardiovascular risk factors. Am J Epidemiol 1987; 126: 86-94.
52. Enzi G et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986; 44: 739-746.
53. Lemieux S et al. Do elevate levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein levels in men? [Abstract]. Atherosclerosis 1994; 109: 143.